Intratio
量化研究
跳转到主要内容
市场摘要
正在加载市场情报...
  • 登录
    我的账户
    登出
AI 90天预测
中性信号
██.█% 免费注册以查看

Cumberland Pharmaceuticals Inc（CPIX）AI预测

我们的AI分析了Cumberland Pharmaceuticals Inc。创建免费账户以查看90天价格预测。

✓ 免费账户 • ✓ 30天免费试用

$CPIX 中性信号 完整预测可用
免费注册

Cumberland Pharmaceuticals Inc (CPIX) 2025年股票预测

Cumberland Pharmaceuticals Inc (CPIX) AI股价预测与投资分析

Cumberland Pharmaceuticals Inc 股价图表和技术分析

正在加载图表...

Cumberland Pharmaceuticals Inc (CPIX) - 全面股票分析与投资研究

深入了解Cumberland Pharmaceuticals Inc的业务概况、财务表现、AI预测和竞争定位，以做出明智的投资决策。

分析更新于 六月 1, 2026, 4:38 p.m. (UTC)

Cumberland Pharmaceuticals Inc投资摘要

在评估Cumberland Pharmaceuticals Inc（CPIX）是否代表一个引人注目的投资机会时，投资者必须考虑多种因素，包括公司的财务状况、市场地位、增长前景，以及我们的AI驱动预测模型对其近期价格走势的预测。

公司概况

Cumberland Pharmaceuticals Inc (CPIX) 位于Life Sciences行业，具体属于Pharmaceutical Preparations业务. . 该公司市值为92百万美元，属于小盘股，可能提供更高的增长潜力，但也伴随更高的波动性。

财务表现分析

我们的全面财务分析涵盖Cumberland Pharmaceuticals Inc的营收、盈利指标、资产负债表实力和现金流生成…

AI价格预测

获取Cumberland Pharmaceuticals Inc的AI驱动7天、30天和90天价格预测，包括置信度评分和详细分析…

投资考量因素

专家分析Cumberland Pharmaceuticals Inc是否适合您的投资目标、风险承受能力和投资期限…

继续阅读完整分析

获取Cumberland Pharmaceuticals Inc的完整投资分析

免费注册
企业身份

Cumberland Pharmaceuticals Inc (股票代码: CPIX) 是在Life Sciences板块运营的知名公司，专注于Pharmaceutical Preparations行业. 该公司的股票在Nasdaq交易所公开交易.

领导层与员工

关于Cumberland Pharmaceuticals Inc领导团队、员工规模和组织结构的详细信息…

市场分类

Cumberland Pharmaceuticals Inc的市值分析和股票分类（超大盘、大盘、中盘、小盘）…

板块与行业分析

Cumberland Pharmaceuticals Inc的深入板块动态和行业背景…

解锁完整公司概况

获取关于Cumberland Pharmaceuticals Inc的完整详情

免费注册
营收与增长分析

Cumberland Pharmaceuticals Inc的年营收为 $38 百万 , 代表一家处于成长阶段的新兴公司。

盈利能力指标

Cumberland Pharmaceuticals Inc的净利率、毛利率和营业利率分析…

市场估值

Cumberland Pharmaceuticals Inc的市盈率、市净率和估值倍数…

回报指标

Cumberland Pharmaceuticals Inc的净资产收益率（ROE）、总资产收益率（ROA）和资本效率…

解锁财务分析

获取Cumberland Pharmaceuticals Inc的完整财务指标

免费注册
AI分析可用

解锁Cumberland Pharmaceuticals Inc的AI价格预测

加入10,000+投资者，使用我们准确率超过67%的AI预测

4,000+ 已分析股票
67%+ 准确率
每日 更新
开始30天免费试用 →

✓ 30天免费试用 • ✓ 随时取消

战略市场地位

Cumberland Pharmaceuticals Inc在高度动态的 Pharmaceutical Preparations市场中战略竞争. 作为小盘公司，它代表具有巨大增长潜力的新兴市场参与者。小盘股在获取市场份额和扩大运营规模时通常提供更大的增长潜力，尽管这伴随着更高的风险和波动性。在这一阶段的成功可以为识别出成功业务模式的早期投资者带来可观回报。

行业竞争格局

Cumberland Pharmaceuticals Inc在Life Sciences板块竞争，应对该行业特有的竞争动态和市场力量。 该公司的竞争地位取决于其通过产品质量、成本效率、客户关系或其他与其特定市场细分相关的战略优势进行差异化的能力。

运营效率

该公司展示了积极的运营效率，每年自由现金流生成达2百万美元 . 正的自由现金流表明企业产生的现金超过运营和资本投资所需，为增长计划或股东回报提供资源。

利润率与定价能力分析

该公司保持91.7%毛利率 反映了卓越的定价能力和/或轻资产商业模式。这一水平的毛利率通常见于软件、制药或奢侈品公司，这些公司的增量生产成本相对于售价微乎其微。这样的利润率表明显著的竞争优势保护公司免受价格竞争。

营业利润率为20.1% 展示了公司在计入所有运营费用（包括研发、销售和营销以及一般管理费用）后将收入转化为营业利润的效率。 这一强劲的营业利润率表明相对于收入基础具有出色的成本控制和高效的组织结构。

资产利用效率

资产周转率为0.54倍，表明 资本密集型行业（如公用事业、房地产或重工业）常见的适度资产周转率。由于运营所需的大量基础设施，这些行业的较低周转率是预期之中的。

财务实力与杠杆

Cumberland Pharmaceuticals Inc (CPIX) 基本面分析与内部交易数据 (季度财务报告)

全面的季度财务数据、盈利趋势、内部交易和机构持仓，用于 Cumberland Pharmaceuticals Inc 股票分析.

深入了解Cumberland Pharmaceuticals Inc的财务健康状况、估值指标和运营效率，以做出明智的投资决策。

了解估值指标

这些指标的含义: 估值指标有助于确定 Cumberland Pharmaceuticals Inc 的股票相对于其收益、资产和市场地位是否定价合理。

如何解读: 较低的市盈率可能表明股票被低估，而较高的市盈率则表明市场对增长的预期。市净率将市值与账面价值进行比较。

对于 Cumberland Pharmaceuticals Inc:

市净率 4.26x
市值 $92M
每股收益 $0.56
每股账面价值 $1.44
每股收入 $2.57
每股自由现金流 $0.13
理解盈利能力指标

这些指标的含义: 这些比率衡量 Cumberland Pharmaceuticals Inc 将收入转化为利润并为股东创造回报的效率。

如何解读: 较高的ROE/ROA表示更好的管理效率。利润率百分比显示不同运营层面的盈利能力。

对于 Cumberland Pharmaceuticals Inc: 53.6%的净资产收益率 表明业绩卓越 股东价值创造.

股本回报率 53.6%
资产回报率 16.3%
毛利率 91.7%
营业利润率 20.1%
净利率 11.6%
税前利润率 19.3%
税率 40.5%
理解财务健康指标

这些指标的含义: 这些比率评估Cumberland Pharmaceuticals Inc履行短期债务和有效管理债务水平的能力。

如何解读: 流动比率>2通常表现良好，速动比率>1显示强劲的流动性。较低的资产负债率表明保守的债务管理。

对于 Cumberland Pharmaceuticals Inc:

资产负债率 2.30x
财务杠杆 3.28x
利息保障倍数 -36.5x
理解现金流指标

这些指标的含义: 现金流指标揭示了Cumberland Pharmaceuticals Inc从运营中产生现金并为增长计划提供资金的能力。

如何解读: 正的经营现金流至关重要。自由现金流显示可用于股息、回购或投资的资金。

对于 Cumberland Pharmaceuticals Inc: $2M 的自由现金流 为股东回报和增长投资提供灵活性.

经营现金流 $20M
自由现金流 $2M
资本支出 -$18M
自由现金流/销售额 4.9%
资本支出/销售额 46.4%
理解运营效率指标

这些指标的含义: 这些比率衡量Cumberland Pharmaceuticals Inc使用资产和管理营运资本的有效性。

如何解读: 较高的周转率表明资产利用效率高。较短的收款期显示有效的信用管理。

对于 Cumberland Pharmaceuticals Inc: 0.54倍的资产周转率 表明有改进空间 资产利用.

资产周转率 0.54x
理解财务报表数据

这些指标的含义: 来自Cumberland Pharmaceuticals Inc损益表和资产负债表的关键数据，显示绝对财务表现。

如何解读: 收入显示业务规模，而利润率表明盈利能力。资产负债表项目揭示财务结构。

对于 Cumberland Pharmaceuticals Inc: 年收入为$38M，Cumberland Pharmaceuticals Inc 代表较小但具有高增长潜力的业务.

损益表
总收入 $38M
营业收入 $20M
净收入 $11M
研发费用 $8M
销售及管理费用 $65M
销售成本 $8M
资产负债表要点 (% 占资产的比例)
负债总额 50%
股息与股东信息
流通股份 15M
增长指标（同比）
净收入增长 11.6%
每股收益增长 9.1%

最新 Cumberland Pharmaceuticals Inc 股票新闻与市场分析

影响Cumberland Pharmaceuticals Inc (CPIX) 股价和投资前景的突发新闻、分析师报告和市场更新。

更多新闻可用

免费注册以阅读所有8篇新闻文章，并了解市场最新动态。

免费注册以阅读更多

Cumberland Pharmaceuticals Inc 竞争对手与同行分析 - Life Sciences 行业

Cumberland Pharmaceuticals Inc在Life Sciences行业中与同行和竞争对手的比较分析，包括AI驱动的预测和关键财务指标。

公司 股票代码 90天AI预测 市值（百万美元） 市盈率 市净率
Aardvark Therapeutics, Inc. AARD ██% $90M x 1.0x
Abbvie Inc. ABBV ██% $385.36B 106.0x x
Abcellera Biologics Inc. ABCL ██% $1.88B x 2.0x
Abeona Therapeutics Inc. ABEO ██% $324M 4.9x 2.2x
Abbott Laboratories ABT ██% $149.10B 23.8x 2.9x
Arbutus Biopharma Corp ABUS ██% $898M 5.6x 3.5x
Abvc Biopharma, Inc. ABVC ██% $34M x 3.2x
Abivax S.A. ABVX ██% $10.42B x x
Acadia Pharmaceuticals Inc ACAD ██% $3.71B 9.9x 3.0x
Adicet Bio, Inc. ACET ██% $87M x 0.6x
Aclaris Therapeutics, Inc. ACRS ██% $635M x 4.4x
Acrivon Therapeutics, Inc. ACRV ██% $62M x 0.7x
Actuate Therapeutics, Inc. ACTU ██% $120M x 11.0x
Accustem Sciences Inc. ACUT ██% $4M x x
Acurx Pharmaceuticals, Inc. ACXP ██% $9M x 1.2x
Adagene Inc. ADAG ██% $256M x 6.8x
Adc Therapeutics Sa ADCT ██% $432M x x
Adial Pharmaceuticals, Inc. ADIL ██% $5M x 1.4x
Aditxt, Inc. ADTX ██% $100K x x
Addex Therapeutics Ltd. ADXN ██% $8M x x
Aeon Biopharma, Inc. AEON ██% $19M x x
Agios Pharmaceuticals, Inc. AGIO ██% $1.74B x 1.6x
Akebia Therapeutics, Inc. AKBA ██% $273M x 10.0x
Akero Therapeutics, Inc. AKRO ██% $4.38B -8.7x 4.6x
Akari Therapeutics Plc AKTX ██% $19M x 1.3x
Aldeyra Therapeutics, Inc. ALDX ██% $106M x 2.5x
Alkermes Plc. ALKS ██% $7.02B 46.0x 4.0x
Allarity Therapeutics, Inc. ALLR ██% $27M x 3.8x
Alumis Inc. ALMS ██% $2.70B x 4.8x
Alnylam Pharmaceuticals, Inc. ALNY ██% $39.97B 127.4x 50.7x
Altimmune, Inc. ALT ██% $593M x 2.1x
Alx Oncology Holdings Inc ALXO ██% $256M x 1.7x
Alzamend Neuro, Inc. ALZN ██% $5M x 2.1x
Amylyx Pharmaceuticals, Inc. AMLX ██% $1.59B x 5.8x
Amphastar Pharmaceuticals, Inc. AMPH ██% $841M 10.6x 1.1x
Amarin Corp Plc\Uk AMRN ██% $304M x 0.7x
Amneal Pharmaceuticals, Inc. AMRX ██% $4.16B 34.1x x
Anaptysbio, Inc ANAB ██% $1.62B x 126.8x
Anebulo Pharmaceuticals, Inc. ANEB ██% $19M x 2.4x
Ani Pharmaceuticals Inc ANIP ██% $1.64B 17.8x 2.9x
Anixa Biosciences Inc ANIX ██% $90M x 6.0x
Annexon, Inc. ANNX ██% $826M x 4.0x
Alto Neuroscience, Inc. ANRO ██% $704M x 2.9x
An2 Therapeutics, Inc. ANTX ██% $156M x 1.9x
Annovis Bio, Inc. ANVS ██% $77M x 24.7x
Apollomics Inc. APLM ██% $31M x x
Apellis Pharmaceuticals, Inc. APLS ██% $5.25B 39.4x 12.7x
Applied Therapeutics, Inc. APLT ██% $15M -0.7x 0.9x
Aprea Therapeutics, Inc. APRE ██% $11M x 0.3x
Apimeds Pharmaceuticals Us, Inc. APUS ██% $21M x 0.2x
Aptevo Therapeutics Inc. APVO ██% $6M x 0.5x
Aquestive Therapeutics, Inc. AQST ██% $500M x x
Arcturus Therapeutics Holdings Inc. ARCT ██% $220M x 1.2x
Ardelyx, Inc. ARDX ██% $1.49B x 10.0x
Arcutis Biotherapeutics, Inc. ARQT ██% $2.68B x 14.2x
Artelo Biosciences, Inc. ARTL ██% $5M x 0.7x
Arvinas, Inc. ARVN ██% $558M x 1.4x
Arrowhead Pharmaceuticals, Inc. ARWR ██% $10.95B x 17.8x
Aspire Biopharma Holdings, Inc. ASBP ██% $7M x 1.8x
Assembly Biosciences, Inc. ASMB ██% $548M x 2.8x
Ascendis Pharma A/S ASND ██% $13.89B x x
Assertio Holdings, Inc. ASRT ██% $151M x 2.0x
Atai Beckley N.V. ATAI ██% $1.67B x 10.4x
Alterity Therapeutics Ltd ATHE ██% $78M x x
Actinium Pharmaceuticals, Inc. ATNM ██% $40M x 17.2x
Atossa Therapeutics, Inc. ATOS ██% $45M x 1.5x
Avenue Therapeutics, Inc. ATXI ██% $990K x 0.8x
Astria Therapeutics, Inc. ATXS ██% $710M -4.7x 3.0x
Aurinia Pharmaceuticals Inc. AUPH ██% $2.00B 6.7x 3.5x
Arrivent Biopharma, Inc. AVBP ██% $1.37B x 4.2x
Avadel Pharmaceuticals Plc AVDL ██% $2.10B -10.2x 21.4x
Atea Pharmaceuticals, Inc. AVIR ██% $374M x 1.6x
Avalo Therapeutics, Inc. AVTX ██% $838M x 12.3x
Axim Biotechnologies, Inc. AXIM ██% $2M x x
Axsome Therapeutics, Inc. AXSM ██% $12.06B x 220.9x
Aytu Biopharma, Inc AYTU ██% $27M -0.3x 1.2x
Azitra, Inc. AZTR ██% $4M x 0.4x
Bridgebio Pharma, Inc. BBIO ██% $12.97B x x
Bridgebio Oncology Therapeutics, Inc. BBOT ██% $718M x 1.9x
Bicara Therapeutics Inc. BCAX ██% $1.43B x 2.8x
Briacell Therapeutics Corp. BCTX ██% $26M x 0.9x
Bicycle Therapeutics Plc BCYC ██% $327M x 0.6x
Bioadaptives, Inc. BDPT ██% $110K x x
Biodexa Pharmaceuticals Plc BDRX ██% $510K x x
Beone Medicines Ltd. BEIGF ██% $36.38B 530.6x 8.8x
Bullfrog Ai Holdings, Inc. BFRG ██% $14M x 2.9x
Biofrontera Inc. BFRI ██% $11M x 1.7x
Bio Green Med Solution, Inc. BGMS ██% $6M x 0.9x
Bausch Health Companies Inc. BHC ██% $2.00B x x
Bioharvest Sciences Inc. BHST ██% $87M x 3.4x
Biohaven Ltd. BHVN ██% $1.22B -4.6x 23.4x
Bioage Labs, Inc. BIOA ██% $767M x 2.0x
Bio Essence Corp BIOE ██% $13M 9.8x x
Biovie Inc. BIVI ██% $11M x 0.7x
Bioxytran, Inc BIXT ██% $4M x x
Biolinerx Ltd. BLRX ██% $17M x x
Belite Bio, Inc BLTE ██% $5.67B x 7.4x
Biomea Fusion, Inc. BMEA ██% $100M x 5.3x
Biomarin Pharmaceutical Inc BMRN ██% $11.07B 41.2x 1.8x
Bristol Myers Squibb Co BMY ██% $116.53B 16.0x 5.8x
Bristol Myers Squibb Co BMYMP ██% $1.73T 287.0x 93.4x
Benitec Biopharma Inc. BNTC ██% $397M x 2.2x
Boundless Bio, Inc. BOLD ██% $32M x 0.4x
Bolt Biotherapeutics, Inc. BOLT ██% $10M x 0.5x
Bio-Path Holdings, Inc. BPTH ██% $2M x x
Bioquest Corp BQST ██% $2M x x
Barinthus Biotherapeutics Plc. BRNS ██% $28M x 0.4x
Bespoke Extracts, Inc. BSPK ██% $1M x x
Bioxcel Therapeutics, Inc. BTAI ██% $36M x x
Beyondspring Inc. BYSI ██% $69M x x
Calcimedica, Inc. CALC ██% $13M x x
Camp4 Therapeutics Corp CAMP ██% $208M -0.1x 4.4x
Can-Fite Biopharma Ltd. CANF ██% $7M x 1.3x
Capricor Therapeutics, Inc. CAPR ██% $1.73B x 6.2x
Carisma Therapeutics Inc. CARM ██% $0.00M 0.0x x
Casi Pharmaceuticals, Inc. CASI ██% $5M -1.4x 2.5x
Perspective Therapeutics, Inc. CATX ██% $449M x 1.3x
Gyre Therapeutics, Inc. CBIO ██% $569M x 5.6x
Cdt Equity Inc. CDT ██% $5M x 1.2x
Cingulate Inc. CING ██% $55M x 2.9x
Cell Source, Inc. CLCS ██% $54M x x
Clene Inc. CLNN ██% $77M x x
Cellectar Biosciences, Inc. CLRB ██% $25M x 7.5x
Clearside Biomedical, Inc. CLSD ██% $4M -2.0x -0.7x
Clearside Biomedical, Inc. CLSDQ ██% $2M x x
Climb Bio, Inc. CLYM ██% $628M x 4.2x
Chemomab Therapeutics Ltd. CMMB ██% $14M x 1.2x
Clearmind Medicine Inc. CMND ██% $4M x x
Compass Pathways Plc CMPS ██% $1.76B x 5.4x
Cnbx Pharmaceuticals Inc. CNBX ██% $110K x x
Cns Pharmaceuticals, Inc. CNSP ██% $8M x 112.4x
Centessa Pharmaceuticals Plc CNTA ██% $6.15B x 12.6x
Connect Biopharma Holdings Ltd CNTB ██% $156M x 3.7x
Canton Strategic Holdings, Inc. CNTN ██% $216M x 0.5x
Context Therapeutics Inc. CNTX ██% $262M x 5.0x
Cocrystal Pharma, Inc. COCP ██% $15M x 3.8x
Cogent Biosciences, Inc. COGT ██% $5.97B x 9.8x
Collegium Pharmaceutical, Inc COLL ██% $1.09B 14.5x 3.5x
Corcept Therapeutics Inc CORT ██% $7.26B 153.3x 11.4x
Coya Therapeutics, Inc. COYA ██% $113M x 2.3x
China Pharma Holdings, Inc. CPHI ██% $32M x 0.9x
Cumberland Pharmaceuticals Inc CPIX ██% $92M x 4.3x
Cannapharmarx, Inc. CPMD ██% $2M x x
Catalyst Pharmaceuticals, Inc. CPRX ██% $3.82B 17.2x 3.8x
Corbus Pharmaceuticals Holdings, Inc. CRBP ██% $140M x 1.1x
Cormedix Inc. CRMD ██% $662M 3.7x 1.5x
Crinetics Pharmaceuticals, Inc. CRNX ██% $3.74B x 2.9x
Cervomed Inc. CRVO ██% $29M x 2.7x
Corvus Pharmaceuticals, Inc. CRVS ██% $1.04B x 4.3x
Cytomx Therapeutics, Inc. CTMX ██% $784M x 2.5x
Contineum Therapeutics, Inc. CTNM ██% $504M x 2.0x
Citius Oncology, Inc. CTOR ██% $74M x 2.1x
Hepion Pharmaceuticals, Inc. CTRVP ██% $20K x 0.0x
Ctt Pharmaceutical Holdings, Inc. CTTH ██% $4M x 5.8x
Citius Pharmaceuticals, Inc. CTXR ██% $18M x 0.3x
Cue Biopharma, Inc. CUE ██% $89M x 4.1x
Curanex Pharmaceuticals Inc CURX ██% $9M x 1.2x
Cadrenal Therapeutics, Inc. CVKD ██% $15M x 8.5x
Cv Sciences, Inc. CVSI ██% $6M x 3.9x
Cyclerion Therapeutics, Inc. CYCN ██% $13M x 2.0x
Cytodyn Inc. CYDY ██% $407M x x
Cypherpunk Technologies Inc. CYPH ██% $120M x 1.4x
Cryoport, Inc. CYRX ██% $788M 9.9x 1.6x
Cytokinetics Inc CYTK ██% $10.42B x x
Dare Bioscience, Inc. DARE ██% $32M x 44.2x
Day One Biopharmaceuticals, Inc. DAWN ██% $2.22B x 5.0x
Decoy Therapeutics Inc. DCOY ██% $5M x 1.2x
Journey Medical Corp DERM ██% $172M x 5.6x
Diamedica Therapeutics Inc. DMAC ██% $323M x 6.8x
Damora Therapeutics, Inc. DMRA ██% $1.53B x 3.0x
Dianthus Therapeutics, Inc. /De/ DNTH ██% $5.08B x 4.2x
Dermata Therapeutics, Inc. DRMA ██% $5M x 0.8x
Bright Minds Biosciences Inc. DRUG ██% $864M x x
Design Therapeutics, Inc. DSGN ██% $654M x 3.0x
Dynavax Technologies Corp DVAX ██% $1.82B 88.2x 3.4x
Dogwood Therapeutics, Inc. DWTX ██% $56M x 0.7x
Dyne Therapeutics, Inc. DYN ██% $3.19B x 3.7x
Emergent Biosolutions Inc. EBS ██% $472M x 0.9x
Edesa Biotech, Inc. EDSA ██% $64M x 6.3x
Eagle Pharmaceuticals, Inc. EGRX ██% $4M 0.4x 0.0x
Pmgc Holdings Inc. ELAB ██% $8M x 0.6x
Elanco Animal Health Inc ELAN ██% $11.91B x 1.8x
Eledon Pharmaceuticals, Inc. ELDN ██% $289M x 6.5x
Elite Pharmaceuticals Inc /Nv/ ELTP ██% $365M 13.4x 4.6x
Elicio Therapeutics, Inc. ELTX ██% $213M x x
Enliven Therapeutics, Inc. ELVN ██% $2.41B x 5.3x
Emmaus Life Sciences, Inc. EMMA ██% $700K x x
Enlivex Ltd. ENLV ██% $195M 0.1x 0.1x
Ensysce Biosciences, Inc. ENSC ██% $4M x x
Enanta Pharmaceuticals Inc ENTA ██% $382M x 3.3x
Gridai Technologies Corp. ENTO ██% $7M 0.0x 0.3x
Enveric Biosciences, Inc. ENVB ██% $8M x 1.7x
Evolus, Inc. EOLS ██% $432M x x
Essa Pharma Inc. EPIX ██% $9M -2.7x 0.1x
Eupraxia Pharmaceuticals Inc. EPRX ██% $463M x 5.7x
Equillium, Inc. EQ ██% $183M x 3.1x
Erasca, Inc. ERAS ██% $3.99B x 10.1x
Ernexa Therapeutics Inc. ERNA ██% $12M x 1.8x
Esperion Therapeutics, Inc. ESPR ██% $787M x x
89bio, Inc. ETNB ██% $2.20B -3.5x 4.2x
Eton Pharmaceuticals, Inc. ETON ██% $833M x 27.2x
Earth Science Tech, Inc. ETST ██% $52M 12.7x 9.0x
Evofem Biosciences, Inc. EVFM ██% $930K x x
Evommune, Inc. EVMN ██% $837M x 2.8x
Edgewise Therapeutics, Inc. EWTX ██% $3.67B x 7.4x
Fuss Brands Corp. FBDS ██% $2M x 0.0x
Fortress Biotech, Inc. FBIO ██% $93M 0.7x 0.6x
Fortress Biotech, Inc. FBIOP ██% $394M 98.8x 7.1x
Fibrobiologics, Inc. FBLG ██% $6M x 2.3x
Forte Biosciences, Inc. FBRX ██% $391M x 9.3x
Fibrogen Inc FGEN ██% $35M 0.2x -3.6x
Foghorn Therapeutics Inc. FHTX ██% $251M x x
Filana Therapeutics, Inc. FLNA ██% $74M x 1.1x
Amicus Therapeutics, Inc. FOLD ██% $4.50B x 16.4x
Fulcrum Therapeutics, Inc. FULC ██% $461M x 1.4x
Galectin Therapeutics Inc GALT ██% $166M x x
Gain Therapeutics, Inc. GANX ██% $83M x 5.9x
Generation Bio Co. GBIO ██% $36M -0.6x 0.7x
Greater Cannabis Company, Inc. GCAN ██% $170K x x
Cytomed Therapeutics Ltd GDTC ██% $14M x x
Geron Corp GERN ██% $816M x 3.6x
Gh Research Plc GHRS ██% $1.49B x x
Galmed Pharmaceuticals Ltd. GLMD ██% $5M x 0.3x
Lakefront Biotherapeutics Nv GLPG ██% $1.85B x x
Greenwich Lifesciences, Inc. GLSI ██% $361M x 165.3x
Galecto, Inc. GLTO ██% $1.59B -2.5x 198.2x
Genelux Corp GNLX ██% $137M x 6.0x
Genprex, Inc. GNPX ██% $8M x 0.5x
Gossamer Bio, Inc. GOSS ██% $54M x x
Geovax Labs, Inc. GOVX ██% $11M x 21.7x
Structure Therapeutics Inc. GPCR ██% $2.80B x 1.9x
Grace Therapeutics, Inc. GRCE ██% $40M x 0.6x
Gridai Technologies Corp. GRDX ██% $37M x 2.0x
Gri Bio, Inc. GRI ██% $4M x 0.4x
Galera Therapeutics, Inc. GRTX ██% $20M 0.1x 27.9x
Gsk Plc GSK ██% $101.38B x x
Gt Biopharma, Inc. GTBP ██% $17M x 2.3x
Gyre Therapeutics, Inc. GYRE ██% $540M x 5.3x
Hutchmed (China) Ltd HCM ██% $1.97B 2.2x 1.6x
Hcw Biologics Inc. HCWB ██% $14M x 2.5x
Cybin Inc. HELP ██% $227M x x
Hepion Pharmaceuticals, Inc. HEPA ██% $2M x 1.0x
Vyome Holdings, Inc HIND ██% $16M x 2.4x
Hutchmed (China) Ltd HMDCF ██% $2.64B x 2.1x
Hookipa Pharma Inc. HOOK ██% $14M x 0.4x
Rocket One Inc. HOTH ██% $24M x 5.7x
Werewolf Therapeutics, Inc. HOWL ██% $22M x 1.8x
Harmony Biosciences Holdings, Inc. HRMY ██% $1.83B 12.6x 2.0x
Heron Therapeutics, Inc. /De/ HRTX ██% $165M x 18.1x
Hst Global, Inc. HSTC ██% $99M x 79.9x
Tuhura Biosciences, Inc./Nv HURA ██% $144M x 6.2x
Mindwalk Holdings Corp. HYFT ██% $82M x x
Hyperion Defi, Inc. HYPD ██% $53M x 0.9x
Ibio, Inc. IBIO ██% $94M x 1.2x
Impact Biomedical Inc. IBO ██% $56M x 4.9x
Ideaya Biosciences, Inc. IDYA ██% $2.59B x 2.8x
Inflarx N.V. IFRX ██% $354M x x
Igc Pharma, Inc. IGC ██% $29M x 4.7x
Immutep Ltd IMMP ██% $65M x x
Immix Biopharma, Inc. IMMX ██% $641M x 7.6x
Immunome Inc. IMNM ██% $2.47B x 4.2x
Imunon, Inc. IMNN ██% $9M x 2.5x
Immuron Ltd IMRN ██% $12M x x
Immuneering Corp IMRX ██% $373M x 1.8x
Eom Pharmaceutical Holdings, Inc. IMUC ██% $6M x 1.8x
Immunic, Inc. IMUX ██% $204M x 1.4x
Integrated Biopharma Inc INBP ██% $6M x 0.3x
Indaptus Therapeutics, Inc. INDP ██% $199M x 159.7x
Indivior Pharmaceuticals, Inc. INDV ██% $4.47B 17.7x x
Inmed Pharmaceuticals Inc. INM ██% $5M x 0.8x
Inovio Pharmaceuticals, Inc. INO ██% $108M x 17.8x
Insmed Inc INSM ██% $23.15B x 32.8x
Inhibitor Therapeutics, Inc. INTI ██% $15M x x
Innoviva, Inc. INVA ██% $1.58B 3.1x 1.2x
Io Biotech, Inc. IOBT ██% $540K x 0.6x
Io Biotech, Inc. IOBTQ ██% $210K x 0.2x
Ionis Pharmaceuticals Inc IONS ██% $12.69B x 25.8x
Opus Genetics, Inc. IRD ██% $355M x x
Disc Medicine, Inc. IRON ██% $2.66B x 3.9x
Ironwood Pharmaceuticals Inc IRWD ██% $588M 5.8x x
International Stem Cell Corp ISCO ██% $1M x x
Iterum Therapeutics Plc ITRM ██% $1M x x
Inventiva S.A. IVA ██% $1.03B x x
Incannex Healthcare Inc. IXHL ██% $40M x 0.5x
Jaguar Health, Inc. JAGX ██% $2M x x
Janux Therapeutics, Inc. JANX ██% $888M x 0.9x
Jazz Pharmaceuticals Plc JAZZ ██% $14.64B 496.4x 3.2x
Jade Biosciences, Inc. JBIO ██% $1.04B x 3.5x
Johnson & Johnson JNJ ██% $542.75B 25.8x 6.7x
Jupiter Neurosciences, Inc. JUNS ██% $11M x x
Kala Bio, Inc. KALA ██% $41M x 3.9x
Kalvista Pharmaceuticals, Inc. KALV ██% $1.38B x x
Kairos Pharma, Ltd. KAPA ██% $11M x 2.1x
Kaya Holdings, Inc. KAYS ██% $23M x x
Kamada Ltd KMDA ██% $451M x x
Kiniksa Pharmaceuticals International, Plc KNSA ██% $3.70B 50.7x 6.1x
Kiora Pharmaceuticals Inc KPRX ██% $7M -2.4x 0.3x
Karyopharm Therapeutics Inc. KPTI ██% $205M x x
Keros Therapeutics, Inc. KROS ██% $222M x 0.8x
Korro Bio, Inc. KRRO ██% $193M x 1.6x
Pasithea Therapeutics Corp. KTTA ██% $24M x 0.4x
Kura Oncology, Inc. KURA ██% $905M x 8.4x
Kyntra Bio, Inc. KYNB ██% $28M 0.2x x
Kezar Life Sciences, Inc. KZR ██% $54M x 0.8x
Lb Pharmaceuticals Inc LBRX ██% $802M x 2.1x
Legend Biotech Corp LEGN ██% $5.04B x x
Lexaria Bioscience Corp. LEXX ██% $15M x 2.3x
Lifecore Biomedical, Inc. \De\ LFCR ██% $188M x x
Lifevantage Corp LFVN ██% $99M 12.6x 3.0x
Ligand Pharmaceuticals Inc LGND ██% $4.65B 30.3x 4.7x
Longeveron Inc. LGVN ██% $24M x 1.5x
Lianbio LIANY ██% $15M x 0.1x
Lftd Partners Inc. LIFD ██% $3M x 0.3x
Lipella Pharmaceuticals Inc. LIPO ██% $460K x 0.3x
Lite Strategy, Inc. LITS ██% $36M x 0.6x
Lixte Biotechnology Holdings, Inc. LIXT ██% $77M x 9.7x
Lixte Biotechnology Holdings, Inc. LIXTW ██% $130K x 0.0x
Lakefront Biotherapeutics Nv LKFT ██% $1.87B x x
Eli Lilly & Co LLY ██% $988.42B 39.1x 31.7x
Lunai Bioworks Inc. LNAI ██% $14M x x
Lipocine Inc. LPCN ██% $17M x 0.7x
Cypherpunk Technologies Inc. LPTX ██% $94M -1.1x 35.1x
Liquidia Corp LQDA ██% $5.46B 244.9x 50.3x
Larimar Therapeutics, Inc. LRMR ██% $362M x 2.3x
Lisata Therapeutics, Inc. LSTA ██% $30M x 2.7x
Lantern Pharma Inc. LTRN ██% $46M x 13.3x
Lava Therapeutics Nv LVTX ██% $46M x 3.6x
Lexicon Pharmaceuticals, Inc. LXRX ██% $928M x 4.6x
Lyell Immunopharma, Inc. LYEL ██% $404M x 1.5x
Maia Biotechnology, Inc. MAIA ██% $85M x 3.0x
Mustang Bio, Inc. MBIO ██% $5M x 0.6x
Moleculin Biotech, Inc. MBRX ██% $15M x 1.0x
Mbx Biosciences, Inc. MBX ██% $1.50B x 3.4x
Seres Therapeutics, Inc. MCRB ██% $70M x 2.7x
Medicus Pharma Ltd. MDCX ██% $21M x 16.2x
Medicus Pharma Ltd. MDCXW ██% $52M x x
Madrigal Pharmaceuticals, Inc. MDGL ██% $11.46B x 21.1x
Chrome Holding Co. MEHCQ ██% $96M x x
Macrogenics Inc MGNX ██% $264M x 12.5x
Mira Pharmaceuticals, Inc. MIRA ██% $45M x 4.8x
Mirum Pharmaceuticals, Inc. MIRM ██% $6.18B x 25.5x
Milestone Pharmaceuticals Inc. MIST ██% $167M x 4.6x
Moonlake Immunotherapeutics MLTX ██% $1.37B x 5.4x
Mineralys Therapeutics, Inc. MLYS ██% $2.60B x 4.1x
Mannkind Corp MNKD ██% $1.16B x x
Medicinova Inc MNOV ██% $67M x 1.7x
Monopar Therapeutics MNPR ██% $436M x 3.2x
Maplight Therapeutics, Inc. MPLT ██% $1.33B x 3.3x
Mereo Biopharma Group Plc MREO ██% $55M x 1.6x
Merck & Co., Inc. MRK ██% $293.48B 32.9x 6.4x
Marker Therapeutics, Inc. MRKR ██% $26M x 1.9x
Mersana Therapeutics, Inc. MRSN ██% $145M -3.4x -1.4x
Merus N.V. MRUS ██% $6.83B -13.5x 8.8x
Maravai Lifesciences Holdings, Inc. MRVI ██% $1.77B x 8.4x
Matinas Biopharma Holdings, Inc. MTNB ██% $5M x 1.7x
Metsera, Inc. MTSR ██% $7.41B x 22.0x
Metavia Inc. MTVA ██% $15M x 1.6x
Mural Oncology Plc MURA ██% $35M x 0.6x
Mainz Biomed N.V. MYNZ ██% $7M x x
Newamsterdam Pharma Co N.V. NAMS ██% $3.93B x 5.9x
Newamsterdam Pharma Co N.V. NAMSW ██% $2.59B x 3.6x
Natures Sunshine Products Inc NATR ██% $374M 18.8x 2.2x
Novabridge Biosciences NBP ██% $213M x 0.8x
Nanobiotix S.A. NBTX ██% $1.49B x x
Stablecoin Development Corp NBY ██% $37M x x
Newcelx Ltd. NCEL ██% $19M x 34.9x
Nucana Plc NCNA ██% $10M x x
Minerva Neurosciences, Inc. NERV ██% $215M x x
Neuphoria Therapeutics Inc. NEUP ██% $29M x 1.0x
Neurogene Inc. NGNE ██% $443M x 1.9x
Nika Pharmaceuticals, Inc NIKA ██% $212M x x
Nektar Therapeutics NKTR ██% $2.19B x 3.8x
Nkarta, Inc. NKTX ██% $241M x 0.8x
Newcelx Ltd. NLSP ██% $54M x 98.9x
Newcelx Ltd. NLSPW ██% $120K x 0.2x
Nanoviricides, Inc. NNVC ██% $39M x 4.2x
Nurix Therapeutics, Inc. NRIX ██% $1.84B x 3.8x
Neurosense Therapeutics Ltd. NRSN ██% $30M x x
Nrx Pharmaceuticals, Inc. NRXP ██% $148M x x
Neonc Technologies Holdings, Inc. NTHI ██% $115M x x
Nuvation Bio Inc. NUVB ██% $1.66B x 5.2x
Nuvalent, Inc. NUVL ██% $8.68B x 7.4x
Nuvectis Pharma, Inc. NVCT ██% $259M x 18.2x
Novartis Ag NVS ██% $286.55B x x
Northwest Biotherapeutics Inc NWBO ██% $370M x x
Nexien Biopharma, Inc. NXEN ██% $10K x x
Nextcure, Inc. NXTC ██% $22M x 0.8x
Nexentis Technologies Inc. NXTS ██% $4M x 0.3x
Ocean Biomedical, Inc. OCEA ██% $190K -0.3x 0.1x
Ocular Therapeutix, Inc OCUL ██% $1.97B x 3.4x
Oragenics Inc OGEN ██% $3M x 0.4x
Organigram Global Inc. OGI ██% $160M x x
Organon & Co. OGN ██% $3.50B 14.2x 3.9x
Onkure Therapeutics, Inc. OKUR ██% $170M x 0.9x
Olema Pharmaceuticals, Inc. OLMA ██% $1.15B x 2.4x
Omeros Corp OMER ██% $795M 9.2x x
Beone Medicines Ltd. ONC ██% $29.87B 58.2x 6.3x
Onconetix, Inc. ONCO ██% $1M x 0.1x
Oncolytics Biotech Inc ONCY ██% $121M x x
Opko Health, Inc. OPK ██% $1.11B x 0.9x
Organogenesis Holdings Inc. ORGO ██% $331M 121.6x 1.4x
Orgenesis Inc. ORGS ██% $3M x x
Oric Pharmaceuticals, Inc. ORIC ██% $874M x 2.1x
Oruka Therapeutics, Inc. ORKA ██% $3.53B x 7.3x
Oramed Pharmaceuticals Inc. ORMP ██% $162M 1.5x 0.7x
Os Therapies Inc OSTX ██% $95M x x
Oncotelic Therapeutics, Inc. OTLC ██% $27M x 0.1x
Ovid Therapeutics Inc. OVID ██% $510M x 2.6x
One World Products, Inc. OWPC ██% $600K x x
Phibro Animal Health Corp PAHC ██% $1.25B 13.1x 3.5x
Prestige Consumer Healthcare Inc. PBH ██% $2.30B 12.1x 1.2x
Psyence Biomedical Ltd. PBM ██% $10M x x
Puma Biotechnology, Inc. PBYI ██% $365M 15.0x 2.8x
Pacira Biosciences, Inc. PCRX ██% $913M 177.7x 1.4x
Processa Pharmaceuticals, Inc. PCSA ██% $7M x 2.7x
Procyon Corp PCYN ██% $2M x 0.7x
Pds Biotechnology Corp PDSB ██% $60M x 15.5x
Pepgen Inc. PEPG ██% $104M x 0.8x
Pfizer Inc PFE ██% $148.99B 19.9x 1.7x
Precigen, Inc. PGEN ██% $1.54B x 76.3x
Phathom Pharmaceuticals, Inc. PHAT ██% $762M x x
Phio Pharmaceuticals Corp. PHIO ██% $13M x 0.8x
Pharvaris N.V. PHVS ██% $2.11B x x
Protokinetix, Inc. PKTX ██% $2M x 9.0x
Plandai Biotechnology, Inc. PLPL ██% $4M x 14.6x
Pliant Therapeutics, Inc. PLRX ██% $78M x 0.5x
Polomar Health Services, Inc. PMHS ██% $2M x 0.3x
Promis Neurosciences Inc. PMN ██% $97M x 1.6x
Pmv Pharmaceuticals, Inc. PMVP ██% $64M x 0.7x
Purple Biotech Ltd. PPBT ██% $3M x x
Propanc Biopharma, Inc. PPCB ██% $4M x 0.4x
Praxis Precision Medicines, Inc. PRAX ██% $9.75B x 6.9x
Prf Technologies Ltd. PRFX ██% $2M x 0.3x
Perrigo Co Plc PRGO ██% $1.53B x 0.6x
Prelude Therapeutics Inc PRLD ██% $323M x 5.4x
Prophase Labs, Inc. PRPH ██% $470K x 0.1x
Proqr Therapeutics N.V. PRQR ██% $166M x x
Prothena Corp Public Ltd Co PRTA ██% $540M x 1.7x
Ptc Therapeutics, Inc. PTCT ██% $6.12B x x
Protagonist Therapeutics, Inc PTGX ██% $6.39B x 9.8x
Protagenic Therapeutics, Inc.\New PTIX ██% $1M x x
Palatin Technologies Inc PTN ██% $25M x 2.4x
Palatin Technologies Inc PTNT ██% $17M x 43.1x
Petros Pharmaceuticals, Inc. PTPI ██% $250K 0.1x 0.1x
Pulmatrix, Inc. PULM ██% $5M x 1.4x
Provectus Biopharmaceuticals, Inc. PVCT ██% $27M x x
Palvella Therapeutics, Inc. PVLA ██% $1.70B x 7.3x
Pyxis Oncology, Inc. PYXS ██% $113M x 3.6x
Aixcrypto Holdings, Inc. QLGN ██% $8M -1.3x 0.2x
Quoin Pharmaceuticals, Ltd. QNRX ██% $10M x 1.2x
Quantum Biopharma Ltd. QNTM ██% $44M x x
Q32 Bio Inc. QTTB ██% $187M 5.6x 4.1x
Quantum Cyber N.V. QUCY ██% $58M x 12.7x
Uniqure N.V. QURE ██% $1.80B x 12.0x
Radiopharm Theranostics Ltd RADX ██% $36M x x
Rani Therapeutics Holdings, Inc. RANI ██% $131M x 4.6x
Rapport Therapeutics, Inc. RAPP ██% $1.89B x 4.0x
Rapt Therapeutics, Inc. RAPT ██% $1.56B -0.4x 10.3x
Ultragenyx Pharmaceutical Inc. RARE ██% $2.35B x x
Rocket Pharmaceuticals, Inc. RCKT ██% $335M x 1.4x
Arcus Biosciences, Inc. RCUS ██% $3.18B x 6.1x
Dr Reddys Laboratories Ltd RDY ██% $11.38B x x
Regeneron Pharmaceuticals, Inc. REGN ██% $63.94B 14.5x 2.0x
Revelation Biosciences, Inc. REVB ██% $4M x 0.3x
Rafael Holdings, Inc. RFL ██% $70M x 0.9x
Regen Biopharma Inc RGBP ██% $150K x x
Regen Biopharma Inc RGBPP ██% $470K x x
Rigel Pharmaceuticals Inc RIGL ██% $561M 1.5x 1.4x
Relmada Therapeutics, Inc. RLMD ██% $756M x 3.5x
Rallybio Corp RLYB ██% $76M x 1.5x
Retrieve Medical Holdings, Inc. RMHI ██% $30M x x
Rockwell Medical, Inc. RMTI ██% $29M x 0.8x
Avidity Biosciences, Inc. RNA ██% $206M -12.2x 0.1x
Cartesian Therapeutics, Inc. RNAC ██% $215M x x
Transcode Therapeutics, Inc. RNAZ ██% $5M x 3.8x
Rein Therapeutics, Inc. RNTX ██% $95M x 8.2x
Renovorx, Inc. RNXT ██% $41M x 3.6x
Roivant Sciences Ltd. ROIV ██% $21.60B x 4.8x
Royalty Pharma Plc RPRX ██% $32.11B 38.8x 4.7x
Repare Therapeutics Inc. RPTX ██% $114M -2.1x 1.0x
Rest Ez Inc. RTEZ ██% $1.93B x x
Rapid Therapeutic Science Laboratories, Inc. RTSL ██% $110K 1.9x 0.3x
Reviva Pharmaceuticals Holdings, Inc. RVPH ██% $5M x 0.3x
Rhythm Pharmaceuticals, Inc. RYTM ██% $6.05B x 49.2x
Rezolute, Inc. RZLT ██% $318M x 2.7x
Filana Therapeutics, Inc. SAVA ██% $101M -1.9x 1.2x
Sunshine Biopharma Inc. SBFM ██% $41M x 1.9x
Scienture Holdings, Inc. SCNX ██% $17M x 0.3x
Scpharmaceuticals Inc. SCPH ██% $302M -2.0x -50.9x
Scorpius Holdings, Inc. SCPX ██% $610K x x
Scynexis Inc SCYX ██% $448M x 10.8x
Stablecoin Development Corp SDEV ██% $34M 0.1x 0.2x
Schrodinger, Inc. SDGR ██% $1.12B x 3.6x
Septerna, Inc. SEPN ██% $1.36B x 3.6x
Serina Therapeutics, Inc. SER ██% $28M x 1.6x
Sagimet Biosciences Inc. SGMT ██% $450M x 4.4x
Shuttle Pharmaceuticals Holdings, Inc. SHPH ██% $3M x 0.9x
Siga Technologies Inc SIGA ██% $336M 16.6x 2.2x
Silo Pharma, Inc. SILO ██% $7M x 1.2x
Sionna Therapeutics, Inc. SION ██% $1.93B x 6.7x
Skinvisible, Inc. SKVI ██% $1M x x
Skye Bioscience, Inc. SKYE ██% $27M x 3.0x
Sol-Gel Technologies Ltd. SLGL ██% $240M x 10.5x
Silence Therapeutics Plc SLN ██% $326M x 6.6x
Silence Therapeutics Plc SLNCF ██% $213M x 2.9x
Soleno Therapeutics Inc SLNO ██% $2.74B 28.6x 5.5x
Salarius Pharmaceuticals, Inc. SLRX ██% $2M -0.5x 0.4x
Sellas Life Sciences Group, Inc. SLS ██% $1.69B x 15.7x
Summit Therapeutics Inc. SMMT ██% $13.61B x 24.9x
Semnur Pharmaceuticals, Inc. SMNR ██% $783M x x
Syndax Pharmaceuticals Inc SNDX ██% $1.73B x 41.7x
Soligenix, Inc. SNGX ██% $13M x 4.4x
Sibannac, Inc. SNNC ██% $2M x x
Sensei Biotherapeutics, Inc. SNSE ██% $28M x x
Sanofi SNY ██% $104.54B x x
Sonnet Biotherapeutics Holdings, Inc. SONN ██% $4M -1.6x 29.5x
Spruce Biosciences, Inc. SPRB ██% $141M x 4.1x
Scisparc Ltd. SPRC ██% $6M x x
Spero Therapeutics, Inc. SPRO ██% $164M 10.8x 3.1x
Ars Pharmaceuticals, Inc. SPRY ██% $901M x 14.7x
Sarepta Therapeutics, Inc. SRPT ██% $1.89B 29.0x 1.3x
Stoke Therapeutics, Inc. STOK ██% $1.88B x 4.8x
Shattuck Labs, Inc. STTK ██% $450M x 4.7x
Supernus Pharmaceuticals, Inc. SUPN ██% $2.68B x 2.5x
Savara Inc SVRA ██% $1.07B x 6.1x
60 Degrees Pharmaceuticals, Inc. SXTP ██% $4M x 0.8x
Synlogic, Inc. SYBX ██% $8M x 0.6x
Spyre Therapeutics, Inc. SYRE ██% $5.59B x 8.3x
Syros Pharmaceuticals, Inc. SYRS ██% $20K -0.1x -0.4x
Takeda Pharmaceutical Co Ltd TAK ██% $50.43B x x
Theravance Biopharma, Inc. TBPH ██% $827M 7.2x 2.9x
Alaunos Therapeutics, Inc. TCRT ██% $7M x 5.3x
Telomir Pharmaceuticals, Inc. TELO ██% $89M x 18.0x
Tenax Therapeutics, Inc. TENX ██% $315M x 2.8x
Terns Pharmaceuticals, Inc. TERN ██% $6.12B x 6.1x
Teva Pharmaceutical Industries Ltd TEVA ██% $40.41B 25.8x 4.9x
Teva Pharmaceutical Industries Ltd TEVJF ██% $38.09B 53.4x 5.3x
Tg Therapeutics, Inc. TGTX ██% $5.71B 12.4x 9.8x
Canton Strategic Holdings, Inc. THAR ██% $186M x 30.2x
Talphera, Inc. TLPH ██% $40M x 2.2x
Telix Pharmaceuticals Ltd TLX ██% $3.18B x x
Tango Therapeutics, Inc. TNGX ██% $3.32B x 8.5x
Tonix Pharmaceuticals Holding Corp. TNXP ██% $197M x 0.9x
Theriva Biologics, Inc. TOVX ██% $13M x 0.9x
Tempest Therapeutics, Inc. TPST ██% $22M x 26.4x
Traws Pharma, Inc. TRAW ██% $17M -0.6x 1.5x
Entrada Therapeutics, Inc. TRDA ██% $265M x 1.0x
Trevi Therapeutics, Inc. TRVI ██% $1.77B x 10.3x
Trevena Inc TRVN ██% $260K -1.3x 1.5x
Turn Therapeutics Inc. TTRX ██% $174M x 28.4x
Tvardi Therapeutics, Inc. TVRD ██% $31M x 2.1x
Travere Therapeutics, Inc. TVTX ██% $4.21B x 42.7x
Therapeuticsmd, Inc. TXMD ██% $23M 130.6x 0.9x
Tyra Biosciences, Inc. TYRA ██% $1.82B x 4.7x
Unicycive Therapeutics, Inc. UNCY ██% $194M x 5.2x
Upstream Bio, Inc. UPB ██% $436M x 1.4x
Urogen Pharma Ltd. URGN ██% $1.29B x x
United Therapeutics Corp UTHR ██% $23.19B 18.0x 3.9x
Vaccinex, Inc. VCNX ██% $2M x x
Vera Therapeutics, Inc. VERA ██% $2.45B x 4.9x
Veru Inc. VERU ██% $39M -0.8x 2.1x
Sb Technology Holdings, Inc. VGLS ██% $710K x x
Sb Technology Holdings, Inc. VGLSD ██% $520K x x
Vicapsys Life Sciences, Inc. VICP ██% $47M x x
Vincerx Pharma, Inc. VINC ██% $70K -0.2x 0.0x
Viracta Therapeutics, Inc. VIRX ██% $390K -0.2x 0.2x
Viking Therapeutics, Inc. VKTX ██% $3.67B x 7.3x
Vanda Pharmaceuticals Inc. VNDA ██% $381M x 1.4x
Verrica Pharmaceuticals Inc. VRCA ██% $99M x 6.1x
Viridian Therapeutics, Inc.\De VRDN ██% $1.73B x 2.7x
Vireo Growth Inc. VREOF ██% $348M x 1.4x
Verona Pharma Plc VRNA ██% $73.55B -185.1x 264.3x
Virpax Pharmaceuticals, Inc. VRPX ██% $160K 0.0x -19.5x
Vertex Pharmaceuticals Inc / Ma VRTX ██% $110.64B 25.5x 5.7x
Verastem, Inc. VSTM ██% $363M x 4.4x
Vistagen Therapeutics, Inc. VTGN ██% $27M x 0.5x
Viatris Inc VTRS ██% $18.42B x 1.3x
Vtv Therapeutics Inc. VTVT ██% $0.00M -3.3x -7.5x
Ventyx Biosciences, Inc. VTYX ██% $999M -1.0x 5.2x
Vyne Therapeutics Inc. VYNE ██% $23M x 0.9x
Whitehawk Therapeutics, Inc. WHWK ██% $212M x 1.8x
Wave Life Sciences Ltd. WVE ██% $1.27B x 2.5x
Xenetic Biosciences, Inc. XBIO ██% $7M x 1.0x
Xbiotech Inc. XBIT ██% $72M x 0.5x
Exicure, Inc. XCUR ██% $19M x 9.1x
Xenon Pharmaceuticals Inc. XENE ██% $5.17B x 3.9x
Xeris Biopharma Holdings, Inc. XERS ██% $1.06B 88.5x 81.7x
Xilio Therapeutics, Inc. XLO ██% $55M x 0.8x
Xencor Inc XNCR ██% $880M x 1.7x
Xoma Royalty Corp XOMA ██% $497M 14.7x 5.4x
Xoma Royalty Corp XOMAO ██% $312M 14.4x 3.6x
Xoma Royalty Corp XOMAP ██% $326M 15.1x 3.7x
Xtl Biopharmaceuticals Ltd XTLB ██% $6M x x
Zenas Biopharma, Inc. ZBIO ██% $1.12B x 3.3x
Zai Lab Ltd ZLAB ██% $1.94B x 2.9x
Zentalis Pharmaceuticals, Inc. ZNTL ██% $285M x 1.6x
Zomedica Corp. ZOMDF ██% $132M x 1.1x
Zoetis Inc. ZTS ██% $32.69B 12.4x 10.1x
Zevra Therapeutics, Inc. ZVRA ██% $689M 5.5x 3.4x
Zyversa Therapeutics, Inc. ZVSA ██% $2M x x
Zymeworks Inc. ZYME ██% $1.75B -8.3x 6.5x
显示所有预测 查看所有竞争对手的精确%预测
免费注册

常见问题 - Cumberland Pharmaceuticals Inc 股票预测

Cumberland Pharmaceuticals Inc的股票预测有多准确？

我们的AI模型对CPIX预测展示了2%的历史准确率，基于超过10年市场数据训练的先进机器学习算法。

哪些因素影响Cumberland Pharmaceuticals Inc的股价预测？

我们的分析考虑了Cumberland Pharmaceuticals Inc的财务指标、Life Sciences行业趋势、市场情绪、技术指标、盈利数据以及影响股票表现的宏观经济因素。

Cumberland Pharmaceuticals Inc在2025年是一项好的投资吗？

根据我们的AI分析，Cumberland Pharmaceuticals Inc显示 各种市场情况的潜力. 在做出投资决策之前，请考虑您的风险承受能力、投资时间表和投资组合多样化。

Cumberland Pharmaceuticals Inc的预测多久更新一次？

Cumberland Pharmaceuticals Inc的股票预测每天使用实时市场数据更新，确保您获得最新的AI驱动的预测和投资见解。

想要Cumberland Pharmaceuticals Inc的更简洁视图吗？

在AI Stock Finder上查看简化分析 →

我的投资组合

投资仪表板

正在加载您的投资组合...